Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Morning ARYC. Only a matter of time.
Thanks for sharing Ken- we're getting close.
Arrayit and COVID-19 Testing + additional company info below.
President Trump's team: “We really want a fingerpick type assay”
https://media.discordapp.net/attachments/684631519259656232/691802593831288903/video0.mov
A few of their marketing partners for Allergy/COVID-19 testing:
https://antibodycovidtest.com/
https://reviveaz.com/covid-19-testing
https://onetouchtelemed.com/
https://www.physicalhealthcarejax.com/at-home-allergy-testing-and-telemedicine/
Arrayit’s COVID-19 blood test order form (pic at bottom of this post). https://vimeo.com/400954846 QUEUE video to 1 minute, 22 seconds
ARRAYIT CoronaVirus Test Instruction:
http://arrayit.com/SARS-CoV-2COVID-19TestInstructions.pdf
Order the COVID-19 Test now: email covid-19@arrayit.com
https://www.arrayit.com/
Dr. Anthony S. Fauci, Director of Allergy and Infectious Disease (NIAID)
..."We must not confuse Allergy symptoms with COVID-19 flu symptoms. We’re in high pollen season trigering Allergies - causing congestion, Rhinitis (runny nose) and Aerophagia (mouth breathing) leading to bacterial sore throat and fever. These symptoms together present as flu and may symptomatically be confused with COVID-19. It’s important we eliminate Allergy as a cause of these symptoms when diagnosing for COVID-19... (paraphrased)"
The science behind how Arrayit tests for COVID-19:
Sensors (Basel). 2017 Sep; 17(9): 2157.
Published online 2017 Sep 20. doi: 10.3390/s17092157
PMCID: PMC5621023
PMID: 28930175
Sensitive Genotyping of Foodborne-Associated Human Noroviruses and Hepatitis A Virus Using an Array-Based Platform
Beatriz Quiñones,1,* Bertram G. Lee,1 Todd J. Martinsky,2 Jaszemyn C. Yambao,1 Paul K. Haje,2 and Mark Schena2
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621023/
Arrayit is now a Medicare in-network provider. Offering one-of-a-kind Allergy Testing that's fast, convenient and most importantly, billable. Review the data that supports this success, and leverage this success for your own clinic.”
https://www.patientdatasolutions.com/medicare.jsp
Centers for Medicare & Medicaid Services:
https://www.cms.gov/apps/clia/clia_start.asp?CLIANum=05D2147467&LabName=&GeoCity=&state=AK&GeoZip=&appType=%25&isSubmitted=clia2
https://npiregistry.cms.hhs.gov/registry/provider-view/1104316157
Arrayit Corporation Approved as New Medicare Part B Healthcare Provider for Allergy Testing Services
https://www.globenewswire.com/news-release/2019/08/12/1900293/0/en/Arrayit-Corporation-Approved-as-New-Medicare-Part-B-Healthcare-Provider-for-Allergy-Testing-Services.html
Extra on Arrayit:
Arrayit recently completed an allergy testing pilot program for a top retail chain, established a nationwide network of 1,700 allergy sales professionals, met with top officials at the United States Food and Drug Administration (FDA) regarding approval of a major product line, fulfilled an FDA clinical instrumentation contract, received approval for in-store promotions by a major retailer, announced allergy testing partnerships with major allergy therapeutics providers, received approval for direct Medicare billing and electronic Medicare reimbursement from the Centers for Medicare and Medicaid Services, launched the Patient Data Solutions allergy portal for doctors and clinics, celebrated 25 years of company operations, announced an allergy testing services agreement with a major health and wellness provider, provided a letter to shareholders from the company's Chief Executive Officer, received endorsement by First Pediatrics Medical Group, announced in-network allergy testing services contracting with a top five commercial health benefits company, doubled its weekly billing guidance to $2 million per week, appointed an Apple enterprise healthcare partner to accelerate revenues and earnings growth, expanded allergy testing services evaluation with a major retail pharmacy chain, grew its allergy testing healthcare network to more than 700 clinics, retained a top credentialing company to accelerate commercial and government payor reimbursement, aced five consecutive rounds of proficiency testing with a top proficiency testing leader, signed an in-network allergy testing services agreement with a major California-based health benefits company, received a certificate of deemed status into 2020 from the California Department of Public Health and expanded its clinic network in Hawaii. Philippines test revenues and earnings will be reported in the company's upcoming audited quarterly and annual financial statements.
CEO Rene Schena states, "Global expansion of our health and wellness testing services in the Philippines is in keeping with our mission to make healthcare more accessible internationally. With universal healthcare coverage and a rising standard of living, the Philippines offers a tremendous growth opportunity for Arrayit and its shareholders as we expand into Southeast Asia and points beyond."
https://www.marketwatch.com/press-release/arrayit-corporation-announces-global-expansion-of-finger-stick-health-and-wellness-testing-services-2019-07-29-61841734?siteid=bigcharts&dist=bigcharts
https://www.twinarborlabs.com
“Cutting Edge Technology. Twin Arbor Analytical utilizes cutting edge technologies such as Arrayit’s (ARYC) proprietary microarray platform. This system was developed as a research cooperative agreement with the United States Department of Agriculture – Agricultural Research Services (USDA-ARS) as a low-cost high throughput system for the analysis of microbial contaminants such as E. coli, salmonella, listeria, Noro virus and Hepatitis A”
Some Marketing partners for allergy testing:
https://lhkv.avtosvet.pro/food/5177-allergy.php
https://www.nationwideallergy.net/
https://birddogpharma.com/allergy-services/
Aspects of the inventions described herein have been described on the website of ARRAYIT® Corporation (arrayit.com) and links thereon. All such disclosures were made by another who obtained the subject matter disclosed directly or indirectly from the inventor of the present application.
https://www.freshpatents.com/-dt20161110ptan20160327567.php
Arrayit’s subsidiary: https://www.telecheminternational.com/
CLIA Laboratory Demographic Information Report: CLIA Number: 05D2147467
https://www.cms.gov/apps/clia/clia_start.asp?CLIANum=05D2147467&LabName=&GeoCity=&state=AK&GeoZip=&appType=%25&isSubmitted=clia2
http://arrayit.com/Clinical/CLIA_Laboratory/clia_laboratory.html
Laboratory Testing Requisition Form:
https://form.jotform.me/92111804789461
Centers for Disease Control and Prevention: Just type in Arrayit or its CLIA number, which is 05D2147467.
https://wwwn.cdc.gov/clia/Resources/LabSearch.aspx#SearchResultsTop
FDA DUNS# 962379470
https://www.usaspending.gov/#/award/67069919
https://www.accessdata.fda.gov/scripts/sda/sdDetailNavigation.cfm?sd=srolist&id=8774BCAC40B16AD6E053564DA8C0CD02&rownum=1
https://www.fpds.gov/ezsearch/fpdsportal?q=arrayit&s=FPDSNG.COM&templateN=&&templateName=1.5.1&indexName=awardfull
http://arrayit.com/Arrayit_Corporation_ARYC_Corpo/Microarray_Media__Press/Arrayit_Corporation_Ships_Clin/arrayit_corporation_ships_clinical_instrumentation_and_software_.html
https://clinicaltrials.gov/ct2/show/NCT03514303
Arrayit is also on the SRO list:
https://www.fda.gov/media/107400/download
SOMETHING FUN THROWN IN:
“ISRC Grant: Purchase Anti-DNA Antibodies as Probes to Prove Validity of Next Generation DNA Microarray Prototypes (Exotic DNA Structures): to Launch a Biotechnology Company-NYIT and Arrayit Corporation (NIH-STTR Grant).”
https://www.nyit.edu/files/academic_affairs/AA_OSPAR_internal_grants_ISRC-TLT_AwardRecipients_2017.pdf
Gagna’s science, which comes as close as possible to recreating the environmental conditions within cells, is sound: He’s already formed a working partnership with Silicon Valley-based manufacturer Arrayit Corp., which has already produced working prototypes.
Gagna is also considering applying for a U.S. Small Business Administration Small Business Technology Transfer (STTR) grant, likely in the $1.5–3 million range. That would be enough funding, he says, to launch a small startup that could market and manufacture the next-gen microarrays.
“If you’re a pharmaceutical company with 50 new chemicals or biologics, you might want to test them out with our microarrays to see if they’re binding with B-DNA, Z-DNA or quadruplex DNA,” he says. “If they are, maybe you can use those new drugs to inhibit gene expression of a disease, and you have your billion-dollar drug.
“This is a cutting-edge approach that can save pharmaceutical companies a lot of time and money, which might result in lower drug prices.”
Arrayit Corp., an 800-pound gorilla in the world of microarrays, is on board and would be part of the STTR grant, bringing its high-end manufacturing, software, and marketing expertise into a potential corporate mix.
“The basic research would be done here at NYIT with our students and the large-scale manufacturing would be done by Arrayit,” Gagna notes. “They believe in the product. They want to be part of the grant. They want to be part of the team.”
Gagna is currently formulating a strategy with NYIT administrators on how to proceed. He estimates a best-case scenario of roughly six years to perfect prototypes and of venture capitalization in order to deliver a fully commercialized product with global potential.
“We already have Arrayit Corp, which knows how to sell microarrays, so we don’t have to go out and hire a sales team,” Gagna says. “And we’re offering researchers two important things: a new approach to studying the structure and function of canonical and exotic DNA and RNA, and a chance to enhance drug-discovery.”
https://www.nyit.edu/box/profiles/faculty_profile_claude_gagna
That’s all true.
Awesome! No one stealing this guys shares.
Yes we will. Exciting to be an ArrayIt shareholder.
And ArrayIt has already been working with them. Makes sense.
Arrayit and COVID-19 Testing + additional company info below.
President Trump's team: “We really want a fingerpick type assay”
https://media.discordapp.net/attachments/684631519259656232/691802593831288903/video0.mov
A few of their marketing partners for Allergy/COVID-19 testing:
https://antibodycovidtest.com/
https://reviveaz.com/covid-19-testing
https://onetouchtelemed.com/
https://www.physicalhealthcarejax.com/at-home-allergy-testing-and-telemedicine/
Arrayit’s COVID-19 blood test order form (pic at bottom of this post). https://vimeo.com/400954846 QUEUE video to 1 minute, 22 seconds
ARRAYIT CoronaVirus Test Instruction:
Everyone have their shares ? Ready for an exciting week ahead.
Buying all I can this week. Can you feel the excitement:)
Thanks for sharing your info- looking like a great week ahead!
“We Now Offer At-Home Allergy Testing And Telemedicine”
https://www.physicalhealthcarejax.com/at-home-allergy-testing-and-telemedicine/
ArrayIT’s Allergy & CoronaVirus Test local coverage in Florida: https://www.actionnewsjax.com/news/local/duval-county/action-news-jax-investigates-jacksonville-chiropractors-claims-surrounding-allergy-testing-that-also-detects-covid-19/BBXPEAWWQVEXVBMZ6M7IWBDHLA/
A few of their marketing partners for Allergy/COVID-19 testing:
https://antibodycovidtest.com/
https://reviveaz.com/covid-19-testing
https://onetouchtelemed.com/
https://www.physicalhealthcarejax.com/at-home-allergy-testing-and-telemedicine/
Arrayit’s COVID-19 blood test order form https://vimeo.com/400954846 QUEUE video to 1 minute, 22 seconds
ARRAYIT CoronaVirus Test Instruction:
Yes - ARYC global giant is coming! Thanks for the links.
Arrayit and COVID-19 Testing + additional company info below.
President Trump's team: “We really want a fingerpick type assay”
https://media.discordapp.net/attachments/684631519259656232/691802593831288903/video0.mov
A few of their marketing partners for Allergy/COVID-19 testing:
https://antibodycovidtest.com/
https://reviveaz.com/covid-19-testing
https://onetouchtelemed.com/
https://www.physicalhealthcarejax.com/at-home-allergy-testing-and-telemedicine/
Arrayit’s COVID-19 blood test order form (pic at bottom of this post). https://vimeo.com/400954846 QUEUE video to 1 minute, 22 seconds
ARRAYIT CoronaVirus Test Instruction:
http://arrayit.com/SARS-CoV-2COVID-19TestInstructions.pdf
Order the COVID-19 Test now: email covid-19@arrayit.com
https://www.arrayit.com/
Dr. Anthony S. Fauci, Director of Allergy and Infectious Disease (NIAID)
..."We must not confuse Allergy symptoms with COVID-19 flu symptoms. We’re in high pollen season trigering Allergies - causing congestion, Rhinitis (runny nose) and Aerophagia (mouth breathing) leading to bacterial sore throat and fever. These symptoms together present as flu and may symptomatically be confused with COVID-19. It’s important we eliminate Allergy as a cause of these symptoms when diagnosing for COVID-19... (paraphrased)"
The science behind how Arrayit tests for COVID-19:
Sensors (Basel). 2017 Sep; 17(9): 2157.
Published online 2017 Sep 20. doi: 10.3390/s17092157
PMCID: PMC5621023
PMID: 28930175
Sensitive Genotyping of Foodborne-Associated Human Noroviruses and Hepatitis A Virus Using an Array-Based Platform
Beatriz Quiñones,1,* Bertram G. Lee,1 Todd J. Martinsky,2 Jaszemyn C. Yambao,1 Paul K. Haje,2 and Mark Schena2
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621023/
Arrayit is now a Medicare in-network provider. Offering one-of-a-kind Allergy Testing that's fast, convenient and most importantly, billable. Review the data that supports this success, and leverage this success for your own clinic.”
https://www.patientdatasolutions.com/medicare.jsp
Centers for Medicare & Medicaid Services:
https://www.cms.gov/apps/clia/clia_start.asp?CLIANum=05D2147467&LabName=&GeoCity=&state=AK&GeoZip=&appType=%25&isSubmitted=clia2
https://npiregistry.cms.hhs.gov/registry/provider-view/1104316157
Arrayit Corporation Approved as New Medicare Part B Healthcare Provider for Allergy Testing Services
https://www.globenewswire.com/news-release/2019/08/12/1900293/0/en/Arrayit-Corporation-Approved-as-New-Medicare-Part-B-Healthcare-Provider-for-Allergy-Testing-Services.html
Extra on Arrayit:
Arrayit recently completed an allergy testing pilot program for a top retail chain, established a nationwide network of 1,700 allergy sales professionals, met with top officials at the United States Food and Drug Administration (FDA) regarding approval of a major product line, fulfilled an FDA clinical instrumentation contract, received approval for in-store promotions by a major retailer, announced allergy testing partnerships with major allergy therapeutics providers, received approval for direct Medicare billing and electronic Medicare reimbursement from the Centers for Medicare and Medicaid Services, launched the Patient Data Solutions allergy portal for doctors and clinics, celebrated 25 years of company operations, announced an allergy testing services agreement with a major health and wellness provider, provided a letter to shareholders from the company's Chief Executive Officer, received endorsement by First Pediatrics Medical Group, announced in-network allergy testing services contracting with a top five commercial health benefits company, doubled its weekly billing guidance to $2 million per week, appointed an Apple enterprise healthcare partner to accelerate revenues and earnings growth, expanded allergy testing services evaluation with a major retail pharmacy chain, grew its allergy testing healthcare network to more than 700 clinics, retained a top credentialing company to accelerate commercial and government payor reimbursement, aced five consecutive rounds of proficiency testing with a top proficiency testing leader, signed an in-network allergy testing services agreement with a major California-based health benefits company, received a certificate of deemed status into 2020 from the California Department of Public Health and expanded its clinic network in Hawaii. Philippines test revenues and earnings will be reported in the company's upcoming audited quarterly and annual financial statements.
CEO Rene Schena states, "Global expansion of our health and wellness testing services in the Philippines is in keeping with our mission to make healthcare more accessible internationally. With universal healthcare coverage and a rising standard of living, the Philippines offers a tremendous growth opportunity for Arrayit and its shareholders as we expand into Southeast Asia and points beyond."
https://www.marketwatch.com/press-release/arrayit-corporation-announces-global-expansion-of-finger-stick-health-and-wellness-testing-services-2019-07-29-61841734?siteid=bigcharts&dist=bigcharts
https://www.twinarborlabs.com
“Cutting Edge Technology. Twin Arbor Analytical utilizes cutting edge technologies such as Arrayit’s (ARYC) proprietary microarray platform. This system was developed as a research cooperative agreement with the United States Department of Agriculture – Agricultural Research Services (USDA-ARS) as a low-cost high throughput system for the analysis of microbial contaminants such as E. coli, salmonella, listeria, Noro virus and Hepatitis A”
Some Marketing partners for allergy testing:
https://lhkv.avtosvet.pro/food/5177-allergy.php
https://www.nationwideallergy.net/
https://birddogpharma.com/allergy-services/
Aspects of the inventions described herein have been described on the website of ARRAYIT® Corporation (arrayit.com) and links thereon. All such disclosures were made by another who obtained the subject matter disclosed directly or indirectly from the inventor of the present application.
https://www.freshpatents.com/-dt20161110ptan20160327567.php
Arrayit’s subsidiary: https://www.telecheminternational.com/
CLIA Laboratory Demographic Information Report: CLIA Number: 05D2147467
https://www.cms.gov/apps/clia/clia_start.asp?CLIANum=05D2147467&LabName=&GeoCity=&state=AK&GeoZip=&appType=%25&isSubmitted=clia2
http://arrayit.com/Clinical/CLIA_Laboratory/clia_laboratory.html
Laboratory Testing Requisition Form:
https://form.jotform.me/92111804789461
Centers for Disease Control and Prevention: Just type in Arrayit or its CLIA number, which is 05D2147467.
https://wwwn.cdc.gov/clia/Resources/LabSearch.aspx#SearchResultsTop
FDA DUNS# 962379470
https://www.usaspending.gov/#/award/67069919
https://www.accessdata.fda.gov/scripts/sda/sdDetailNavigation.cfm?sd=srolist&id=8774BCAC40B16AD6E053564DA8C0CD02&rownum=1
https://www.fpds.gov/ezsearch/fpdsportal?q=arrayit&s=FPDSNG.COM&templateN=&&templateName=1.5.1&indexName=awardfull
http://arrayit.com/Arrayit_Corporation_ARYC_Corpo/Microarray_Media__Press/Arrayit_Corporation_Ships_Clin/arrayit_corporation_ships_clinical_instrumentation_and_software_.html
https://clinicaltrials.gov/ct2/show/NCT03514303
Arrayit is also on the SRO list:
https://www.fda.gov/media/107400/download
SOMETHING FUN THROWN IN:
“ISRC Grant: Purchase Anti-DNA Antibodies as Probes to Prove Validity of Next Generation DNA Microarray Prototypes (Exotic DNA Structures): to Launch a Biotechnology Company-NYIT and Arrayit Corporation (NIH-STTR Grant).”
https://www.nyit.edu/files/academic_affairs/AA_OSPAR_internal_grants_ISRC-TLT_AwardRecipients_2017.pdf
Gagna’s science, which comes as close as possible to recreating the environmental conditions within cells, is sound: He’s already formed a working partnership with Silicon Valley-based manufacturer Arrayit Corp., which has already produced working prototypes.
Gagna is also considering applying for a U.S. Small Business Administration Small Business Technology Transfer (STTR) grant, likely in the $1.5–3 million range. That would be enough funding, he says, to launch a small startup that could market and manufacture the next-gen microarrays.
“If you’re a pharmaceutical company with 50 new chemicals or biologics, you might want to test them out with our microarrays to see if they’re binding with B-DNA, Z-DNA or quadruplex DNA,” he says. “If they are, maybe you can use those new drugs to inhibit gene expression of a disease, and you have your billion-dollar drug.
“This is a cutting-edge approach that can save pharmaceutical companies a lot of time and money, which might result in lower drug prices.”
Arrayit Corp., an 800-pound gorilla in the world of microarrays, is on board and would be part of the STTR grant, bringing its high-end manufacturing, software, and marketing expertise into a potential corporate mix.
“The basic research would be done here at NYIT with our students and the large-scale manufacturing would be done by Arrayit,” Gagna notes. “They believe in the product. They want to be part of the grant. They want to be part of the team.”
Gagna is currently formulating a strategy with NYIT administrators on how to proceed. He estimates a best-case scenario of roughly six years to perfect prototypes and of venture capitalization in order to deliver a fully commercialized product with global potential.
“We already have Arrayit Corp, which knows how to sell microarrays, so we don’t have to go out and hire a sales team,” Gagna says. “And we’re offering researchers two important things: a new approach to studying the structure and function of canonical and exotic DNA and RNA, and a chance to enhance drug-discovery.”
https://www.nyit.edu/box/profiles/faculty_profile_claude_gagna
And more and more clinics should see the importance of this test and sign up. It's a no brainer.
Great April News: $ARYC has 1400 clinics for both allergy and coved-19 test nationwide!
https://www.google.com/amp/s/www.actionnewsjax.com/news/local/duval-county/action-news-jax-investigates-jacksonville-chiropractors-claims-surrounding-allergy-testing-that-also-detects-covid-19/BBXPEAWWQVEXVBMZ6M7IWBDHLA/%3foutputType=amp
Thanks for all your Huge DD my friend.
More and more coming to light! Couldn't be happier with the recent developments.
https://antibodycovidtest.com/
Beyond huge! Covered by insurance companies.
Can you feel the excitement rok?
yes sir!
Recap for those who need it:
On 3-11-19 they increased weekly guidance to 2 mil billing per week. Pasted below.
On 5-8-19, Arrayit had 700 clinics signed up.
Pasted below.
Currently if we have 1400 clinics signed up, could that mean 4-5 mil/week billing:)!
5-8-19: Arrayit microarray manufacturing team completes $27.9 million production run to build allergy testing services inventory for our rapidly expanded network of 700 healthcare clinics using our physician-ordered allergy and asthma tests for patient wellness http://arrayit.com/Clinical/Allergy_Test/allergy_test.html …
3-11-19: Sunnyvale, March 11, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, increases weekly guidance for medical billing associated with its physician-prescribed allergy testing services from $1,000,000 ($1 million) per week as presented in the December 31 2018 CEO Letter to Shareholders, to $2,000,000 ($2 million) per week effective immediately. The 100% weekly guidance increase from $1 million to $2 million per week for fiscal year 2019 (FY2019) is based on medical billing growth during the first quarter of FY2019, the number of new clinics being added to our Patient Data Solutions portal, and the rate of allergy testing services adoption in the marketplace.
That's the truth.
Thanks for the great news! 1400 clinics:)
repost:
On Friday, Haje sent Action News Jax the following statement:
“Thank you for the fair and unbiased reporting.
"As a result of your good work, Arrayit has put a review process in place to examine the messaging and educate the Clinics on how to properly communicate to their patient base. Arrayit has assigned an Executive with a degree in Journalism to conduct the reviews.
"This applies to all 1,400 clinics in the United States that offers the COVID-19 Antibody Screen in addition to the Allergy Test.
"Arrayit believes it is an important test to make available and wants the patients to be able to make an informed decision on the test should they decide to take it. Arrayit is using the news piece as a breeder document to help educate the Clinics offering the test.
"Thank you for your work and bringing this to our attention, these are scary times and precise and accurate reporting is critical for all of us, your viewers”
https://www.actionnewsjax.com/news/local/duval-county/action-news-jax-investigates-jacksonville-chiropractors-claims-surrounding-allergy-testing-that-also-detects-covid-19/BBXPEAWWQVEXVBMZ6M7IWBDHLA/?_website=cmg-tv-10050
Never been more excited to be an Arrayit shareholder.
Hi- welcome to the board and GREAT first post! Big news that came out today. Next week will be fun for longs:)
https://www.actionnewsjax.com/news/local/duval-county/action-news-jax-investigates-jacksonville-chiropractors-claims-surrounding-allergy-testing-that-also-detects-covid-19/BBXPEAWWQVEXVBMZ6M7IWBDHLA/
Disagree - Aryc capable of large production runs that will be needed imo:
ex:
8-8-19: Arrayit clinical team commences $240,000,000 test kit manufacturing run to build inventory for our rapidly expanding physician-ordered finger stick allergy testing services empowering clinic network doctors to identify, manage and treat allergy and asthma http://arrayit.com/Clinical/Allergy_Test/allergy_test.html …
Arrayit clinical team commences $240,000,000 test kit manufacturing run to build inventory for our rapidly expanding physician-ordered finger stick allergy testing services empowering clinic network doctors to identify, manage and treat allergy and asthma https://t.co/To67BQtJJq pic.twitter.com/N4Sy6NFZgJ
— Arrayit Corporation (@arrayit) August 8, 2019
Testing worldwide. Arrayit already has connections in other countries. Plenty of business available for a company like Arrayit that has an accurate test!
Great screen shot PSA ! It's coming!
That’s true. Or financials! A lot to look forward to.
Antibody tests are days away. Arrayit FDA approval days away:)
Ready for next week. It’s an exciting time to be an ArrayIt shareholder.
It’s looking good! Wonder what they’re up to here.
Arrayit's network is growing and growing.
Another green day- we're getting very close now:)! Have a good weekend all.
Agree- 25 years in business right? Long term investors will be well rewarded - all about the technology.
MASSIVE ARYC COVID-19 NEWS and the science behind it- Email update at bottom.
President Trump's team: “We really want a fingerpick type assay”
https://media.discordapp.net/attachments/684631519259656232/691802593831288903/video0.mov
ARRAYIT CoronaVirus Test Approved!!
www.arrayit.com/SARS-CoV-2COVID-19TestInstructions.pdf
Order the COVID-19 Test now! covid-19@arrayit.com
https://www.arrayit.com/
The science behind how Arrayit tests for COVID-19 among others - thanks for sharing.
Sensors (Basel). 2017 Sep; 17(9): 2157.
Published online 2017 Sep 20. doi: 10.3390/s17092157
PMCID: PMC5621023
PMID: 28930175
Sensitive Genotyping of Foodborne-Associated Human Noroviruses and Hepatitis A Virus Using an Array-Based Platform
Beatriz Quiñones,1,* Bertram G. Lee,1 Todd J. Martinsky,2 Jaszemyn C. Yambao,1 Paul K. Haje,2 and Mark Schena2
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621023/
Arrayit is now a Medicare in-network provider. Offering one-of-a-kind Allergy Testing that's fast, convenient and most importantly, billable. Review the data that supports this success, and leverage this success for your own clinic.”
https://www.patientdatasolutions.com/medicare.jsp
Centers for Medicare & Medicaid Services:
https://www.cms.gov/apps/clia/clia_start.asp?CLIANum=05D2147467&LabName=&GeoCity=&state=AK&GeoZip=&appType=%25&isSubmitted=clia2
https://npiregistry.cms.hhs.gov/registry/provider-view/1104316157
Arrayit Corporation Approved as New Medicare Part B Healthcare Provider for Allergy Testing Services
https://www.globenewswire.com/news-release/2019/08/12/1900293/0/en/Arrayit-Corporation-Approved-as-New-Medicare-Part-B-Healthcare-Provider-for-Allergy-Testing-Services.html
Extra on Arrayit:
Arrayit recently completed an allergy testing pilot program for a top retail chain, established a nationwide network of 1,700 allergy sales professionals, met with top officials at the United States Food and Drug Administration (FDA) regarding approval of a major product line, fulfilled an FDA clinical instrumentation contract, received approval for in-store promotions by a major retailer, announced allergy testing partnerships with major allergy therapeutics providers, received approval for direct Medicare billing and electronic Medicare reimbursement from the Centers for Medicare and Medicaid Services, launched the Patient Data Solutions allergy portal for doctors and clinics, celebrated 25 years of company operations, announced an allergy testing services agreement with a major health and wellness provider, provided a letter to shareholders from the company's Chief Executive Officer, received endorsement by First Pediatrics Medical Group, announced in-network allergy testing services contracting with a top five commercial health benefits company, doubled its weekly billing guidance to $2 million per week, appointed an Apple enterprise healthcare partner to accelerate revenues and earnings growth, expanded allergy testing services evaluation with a major retail pharmacy chain, grew its allergy testing healthcare network to more than 700 clinics, retained a top credentialing company to accelerate commercial and government payor reimbursement, aced five consecutive rounds of proficiency testing with a top proficiency testing leader, signed an in-network allergy testing services agreement with a major California-based health benefits company, received a certificate of deemed status into 2020 from the California Department of Public Health and expanded its clinic network in Hawaii. Philippines test revenues and earnings will be reported in the company's upcoming audited quarterly and annual financial statements.
CEO Rene Schena states, "Global expansion of our health and wellness testing services in the Philippines is in keeping with our mission to make healthcare more accessible internationally. With universal healthcare coverage and a rising standard of living, the Philippines offers a tremendous growth opportunity for Arrayit and its shareholders as we expand into Southeast Asia and points beyond."
https://www.marketwatch.com/press-release/arrayit-corporation-announces-global-expansion-of-finger-stick-health-and-wellness-testing-services-2019-07-29-61841734?siteid=bigcharts&dist=bigcharts
ALL i say is my opinion only.
InvestorsHub NewsWire
Featured NexTech Reports Record Breaking
Large production runs happening now imo for Allergy/COVID-19 testing.
similar to:
8-8-19: Arrayit clinical team commences $240,000,000 test kit manufacturing run to build inventory for our rapidly expanding physician-ordered finger stick allergy testing services empowering clinic network doctors to identify, manage and treat allergy and asthma http://arrayit.com/Clinical/Allergy_Test/allergy_test.html …
Arrayit clinical team commences $240,000,000 test kit manufacturing run to build inventory for our rapidly expanding physician-ordered finger stick allergy testing services empowering clinic network doctors to identify, manage and treat allergy and asthma https://t.co/To67BQtJJq pic.twitter.com/N4Sy6NFZgJ
— Arrayit Corporation (@arrayit) August 8, 2019